GlycoNex wins Japan nod to launch first human trial of lead program in gastrointestinal cancers
The upcoming multi-center, multinational Phase 1 study will evaluate safety, tolerability, pharmacokinetics, and early signs of efficacy
The upcoming multi-center, multinational Phase 1 study will evaluate safety, tolerability, pharmacokinetics, and early signs of efficacy
Strategic expansion strengthens CDMO’s support for biotech and pharma innovators across the Asia-Pacific region
The ninth edition of the event brought together over 800 delegates, more than 60 national and international speakers, and 20+ partner organisations across 10 sessions
The goal is to better support drug developers as programs move from laboratory research into clinical trials
Outlines 1,500-member internal cadre, digital regulatory system, and faster SEC-led reviews
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
This event will bring together global stakeholders to explore India’s growing capabilities in pharma and biopharma innovation, research, and manufacturing
The company says the platform offers improved manufacturability and functional advantages
The solution integrates key molecular cloning methods—including Golden Gate, Gibson assembly, and restriction/ligation—alongside primer design, Sanger sequencing analysis, and protein translation in a single application
Three-day programme equips CSIR researchers with advanced AI tools, molecular docking insights, and biomolecular simulation expertise
Subscribe To Our Newsletter & Stay Updated